Senores Pharmaceuticals expands US footprint with Roflumilast ANDA acquisition
Senores Pharmaceuticals Limited has taken a significant step in its US expansion strategy by acquiring an Abbreviated New Drug Application (ANDA) for Roflumilast 250 mcg ... Read More
Arcutis Biotherapeutics gets ZORYVE FDA approval for seborrheic dermatitis
Arcutis Biotherapeutics, Inc., a pioneer in immuno-dermatology, has announced the U.S. Food and Drug Administration's (FDA) approval of their new drug application for ZORYVE (roflumilast) ... Read More